CIN-1: 90% regress with two years, 11% progress to CIN-3, 1% progress to invasive cancer CIN-2: 50% regress within two years, 22% progress to CIN-3, 5% progress to invasive cancer CIN-3: 12% progress to invasive cancer Cervical cancer4 ...
Is cervical cancer a sexually transmitted disease? Can a person die from cervical cancer? Is cervical cancer common after pregnancy? Do cervical cancer symptoms come and go? Is cervical and uterine cancer the same? Can cervical cancer spread to the bladder? Is cervical cancer contagious? What is...
The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of prophylactic quadrivalent HPV vaccine in the treatment of women with cervical intraepithelial neoplasia (CIN 1–3). Methods This randomized controlled trial was ...
Cancer Epidemiol Biomarkers Prev 26: 95–103. Article Google Scholar Castle PE, Stoler MH, Solomon D, Schiffman M (2007) The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol...
The study aimed to identify predictors of significant pathology in cervical cancer screening patients with ASC-H smear. “Significant pathology” was defined as the presence of CIN2, CIN3, adenocarcinoma in situ (AIS), or cervical cancer, respectively, CIN2+, in the histopathological findings of...
Despite the knowledge that HPV is responsible for high-grade CIN and cervical cancer, little is known about the use of therapeutic vaccines as a treatment. We aimed to synthesize and critically evaluate the evidence from clinical trials on the safety, efficacy, and immunogenicity of therapeutic vac...